Sarcomeric tropomodulin (Tmod) isoforms, Tmod1 and Tmod4, cap thin filament pointed ends and functionally interact with leiomodin (Lmod) isoforms, Lmod2 and Lmod3, to control myofibril organization, thin filament lengths, and actomyosin crossbridge formation in skeletal muscle fibers. Here, we show that Tmod4 is more abundant than Tmod1 on both the transcript and protein levels in a variety of muscle types, but the relative abundances of sarcomeric Tmods are muscle-specific. We then generate Tmod4 -/-mice, which exhibit normal thin filament lengths, myofibril organization, and skeletal muscle contractile function due to compensatory upregulation of Tmod1, together with an Lmod isoform switch wherein Lmod3 is downregulated and Lmod2 is upregulated. However, RNAi depletion of Tmod1 from either wild-type or Tmod4 -/-muscle fibers leads to thin filament elongation by ~15%.
INTRODUCTION
The semicrystalline arrays of interdigitating, uniform-length actin (thin) and myosin (thick) filaments found in the contracting sarcomeres of skeletal muscle fibers represent a striking example of long-range cytoskeletal organization and precise organelle size control. While thick filament lengths are essentially constant in all skeletal muscles and species examined (~1.65 µm), thin filament lengths vary substantially across muscles and vertebrate species (0.95-1.40 µm) (Castillo et al., 2009; Gokhin et al., 2012; Gokhin et al., 2010; Granzier et al., 1991; Ringkob et al., 2004) . Thin filament lengths are remarkably plastic during normal postnatal skeletal muscle development and aging (Gokhin et al., 2014a) but can become misspecified in some congenital myopathies. For example, thin filaments are abnormally short due to aberrant F-actin assembly and/or destabilization in some nemaline myopathies (Ochala et al., 2012; Ottenheijm et al., 2010; Ottenheijm et al., 2009; Yuen et al., 2014) , while thin filaments elongate due to pointed-end uncapping and actin subunit addition in mouse models of Duchenne muscular dystrophy (Gokhin et al., 2014b) . Misspecification of thin filament lengths frequently occurs with alterations in thin filament activation and/or actomyosin crossbridge formation (Chandra et al., 2009; Ochala et al., 2012; Ottenheijm et al., 2013; Ottenheijm et al., 2010) .
Critical players in the simultaneous regulation of thin filament lengths, thin filament activation, and actomyosin crossbridge formation are the tropomodulin (Tmod) family of tropomyosin (TM)-binding and actin filament pointed-end capping proteins. Vertebrate skeletal muscles contain two sarcomeric Tmod isoforms: Tmod1, expressed in diverse, terminally differentiated cells, including striated muscle, but also erythrocytes, neurons, and ocular lens fiber cells; and Tmod4, which is exclusive to skeletal muscle fibers (AlmenarQueralt et al., 1999; Conley et al., 2001; Gokhin and Fowler, 2011b; Yamashiro et al., 2012) .
Two sarcomeric Tmod molecules cap each thin filament pointed end and bind to the Ntermini of the terminal α/βTM molecules on the thin filaments (Almenar-Queralt et al., 1999; Fowler et al., 1993; Gokhin and Fowler, 2011b; Gokhin et al., 2012; Gokhin et al., 2010; Gokhin et al., 2014b) . Tmod4 is ~10-fold more abundant than Tmod1 in a mixture of isolated tibialis anterior (TA) and extensor digitorum longus (EDL) myofibrils (Gokhin et al., 2014b) , indicating that Tmod4 is likely the predominant pointed-end cap in skeletal muscle thin filaments, at least in fast muscle. In addition, an extrasarcomeric Tmod isoform, Tmod3, caps the pointed ends of cytoplasmic γ-actin filaments in a sarcoplasmic reticulum (SR)-Development • Advance article associated cytoskeletal network (Gokhin and Fowler, 2011a) . Skeletal muscle also contains two leiomodin (Lmod) isoforms, Lmod2 and Lmod3, which are larger Tmod family members that nucleate F-actin assembly and can antagonize Tmods' capping activity (Chereau et al., 2008; Conley et al., 2001; Tsukada et al., 2010; Yuen et al., 2014) .
Tmod perturbation studies in cultured cardiomyocytes and Drosophila indirect flight muscle have demonstrated that sarcomeric Tmods control thin filament lengths by dynamically regulating actin subunit association/dissociation from pointed ends (Bliss et al., 2014; Gregorio et al., 1995; Littlefield et al., 2001; Mardahl-Dumesnil and Fowler, 2001; Sussman et al., 1998) and by stabilizing pointed ends via their interactions with terminal α/βTMs (Mudry et al., 2003) . A role for sarcomeric Tmods in regulating thin filament lengths has also been implicated in mammalian skeletal muscle, where calpain-mediated proteolysis of sarcomeric Tmods in dystrophic muscle is associated with thin filament elongation (Gokhin et al., 2014b) , although potential indirect effects due to non-Tmod-related mechanisms have not been ruled out. However, recent analyses of mouse knockouts have uncovered more complex functions of sarcomeric Tmods in mammalian skeletal muscle contractility, as well as unexpected compensatory mechanisms. In Tmod1 -/-muscle, Tmod3 compensates for absence of Tmod1 by translocating from its SR compartment to the thin filament pointed ends to preserve normal skeletal muscle development, myofibril assembly, and thin filament lengths (Gokhin and Fowler, 2011a; Gokhin et al., 2010) . The switch from pointed-end capping by Tmod1 and Tmod4 in wild-type muscle to pointed-end capping by Tmod3 and Tmod4 in Tmod1 -/-muscle impairs initial α/βTM movement during thin filament activation, inhibiting formation of productive actomyosin crossbridges and depressing isometric force production (Ochala et al., 2014) .
While analyses of dystrophic and Tmod1 -/-skeletal muscles have provided substantial insights into how sarcomeric Tmods regulate thin filament lengths and muscle physiology, direct evidence for Tmod-mediated regulation of skeletal muscle thin filament lengths has not been found. Additionally, the ~10-fold greater abundance of Tmod4 than Tmod1 in TA and EDL myofibrils (Gokhin et al., 2014b) led us to hypothesize that Tmod4's properties at pointed ends are distinct from those of Tmod1. Here, we report that Tmod4 is more abundant than Tmod1 on both the transcript and protein levels in both fast-and slow-switch muscles, but molar ratios of sarcomeric Tmods are muscle-specific. We then generated a novel Tmod4 
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RESULTS
Gene expression and protein abundance of sarcomeric Tmods
To determine whether the relative abundances of Tmod4:Tmod1 are fixed or variable across muscle types, we performed quantitative western blotting of diverse skeletal muscles (TA, soleus, and diaphragm) lysates and determined the molar ratio of sarcomeric Tmods in each muscle. Tmod4 was more abundant than Tmod1 in all muscles examined, but Tmod4 ranged from ~9-10-fold more abundant than Tmod1 in TA, ~4-fold more abundant in soleus, and ~3-fold more abundant in diaphragm ( Table 1 ), indicating that sarcomeric Tmod isoform distributions are muscle type-dependent. In all muscles, ~2 sarcomeric Tmods were associated with each thin filament pointed end (Table 1) , as observed previously (Gokhin et al., 2014b) . Note that the higher Tmod1 levels observed in soleus and diaphragm muscles (Table 1 ) might be due to the heavier vascularization of these muscles and presence of Tmod1-containing erythrocytes (Moyer et al., 2010) . However, this is unlikely, as we do not observe noteworthy differences in Tmod1 abundances in isolated myofibrils vs. wholemuscle lysates (compare Table 1 and (Gokhin et al., 2014b) ). Alternatively, slow muscles such as the soleus and diaphragm might contain more extrasarcomeric Tmod1 than fast muscles, possibly associated with the SR or T-tubules (Gokhin and Fowler, 2011a), leading to higher total Tmod1 levels.
Next, to determine whether greater abundance of Tmod4 as compared to Tmod1 in various skeletal muscles could be explained by differences in gene expression, we analyzed expression of Tmod genes in diverse striated muscles (TA, soleus, diaphragm, and cardiac left ventricle (LV)) using RNA-seq. Tmod4 mRNA was more abundant than Tmod1 mRNA in TA, soleus, and diaphragm (Fig. 1A) , consistent with the higher levels of Tmod4 protein in these muscles (Table 1) and confirmed by qRT-PCR (Fig. 1B) . In contrast, Tmod1 mRNA was more abundant than Tmod4 mRNA in LV (Fig. 1A) , as expected (Gokhin and Fowler, 2011b) . Therefore, muscle-specific molar ratios of Tmod4:Tmod1 proteins correlate with mRNA levels.
To complete our survey of Tmod family gene expression, we examined expression of nonsarcomeric Tmod genes, as well as Lmod genes. Expression of Tmod3 mRNA was low but above-background in all striated muscles examined (Fig. 1A) , consistent with Tmod3's Development • Advance article SR association with γcyto-actin (Gokhin and Fowler, 2011a) , an actin isoform that is ~1/4000 th as abundant as the αsk-actin that comprises the thin filaments (Hanft et al., 2006) . Lmod2 and Lmod3 mRNAs were detected in all striated muscles, in agreement with previous studies (Cenik et al., 2015; Chereau et al., 2008; Conley et al., 2001; Nworu et al., 2015; Tian et al., 2015; Yuen et al., 2014) , but an unexpected muscle type dependence was observed, with
Lmod2 mRNA predominating in slow-twitch soleus, diaphragm, and left ventricular muscles and Lmod3 mRNA more highly expressed than Lmod2 mRNA in fast-twitch TA muscle (Fig.   1C ). Tmod2 and Lmod1 mRNAs were not detected in striated muscles (Fig. 1A ,C), consistent with Tmod2 expression being restricted to neuronal tissues (Cox et al., 2003; Watakabe et al., 1996) and Lmod1 expression being restricted to smooth muscle (Conley et al., 2001; Nanda and Miano, 2012) .
Deletion of Tmod4 induces compensatory upregulation of Tmod1 to maintain normal myofibril organization, thin filament lengths, and muscle function
Because Tmod4 and not Tmod1 is the predominant sarcomeric Tmod isoform in mouse skeletal muscles (Table 1) , we explored the effects of Tmod4 deficiency in mice by generating Tmod4 -/-mice, which lack Tmod4 protein in skeletal muscle ( Fig. 2A-C) . 
Deletion of Tmod4 alters the expression of striated muscle Lmod isoforms
Tmod4 has been proposed to functionally interact with the actin nucleator Lmod3 near the thin filament pointed ends, based on a dramatic decrease in Tmod4 protein levels in Lmod3-deficient nemaline myopathy patients (Yuen et al., 2014) , and the ability of Tmod4 and Lmod3 to substitute for one another during skeletal myofibril assembly in Xenopus (Nworu et al., 2015) . To evaluate this functional interaction, we examined whether deletion of Tmod4 might impact the localization or levels of Lmod3. In both Tmod4 +/+ and Tmod4 -/-muscles, Lmod3 localized to striations at or near the thin filament pointed ends ( Fig. 4C ), as expected (Nworu et al., 2015; Yuen et al., 2014) . The Lmod3 striations were ~0.95 µm from the Z-line ( Fig. 4D ), coincident with neb-N and not the thin filament pointed end where Tmods are located (compare to Fig. 3G ). We were also unable to detect Tmod-Lmod associations by coimmunoprecipitation ( Fig. S3) .
Surprisingly, western blotting of Tmod4 -/-muscle lysates revealed a ~60% decrease in Lmod3 protein levels, with a corresponding increase in Lmod2 (Fig. 4E,F ). These changes in Lmod isoform levels are due to corresponding changes in Lmod3 and Lmod2 mRNA levels ( Gokhin and Fowler, 2011a; Gokhin et al., 2010) ).
To overcome this, we depleted Tmod1 from adult muscles using in vivo RNAi, in which we injected Tmod4 +/+ and Tmod4 -/-TA muscles with either negative-control siRNA (siScr) or one of two Tmod1-targeting siRNAs (siTmod1a and siTmod1b). Muscle fibers from siScrinjected TA muscles consistently exhibited striated Tmod1 staining, whereas fibers from siTmod1a-and siTmod1b-injected muscles showed widespread loss of striated Tmod1 staining in many fibers ( Fig. 5A,B; Fig. S4 ). Extent of knockdown was quantified as the percentage of fibers with striated Tmod1 staining, which was ~100% for siScr-injected TA muscles but reduced to ~25-50% for siTmod1a-and siTmod1b-injected muscles (Fig. 5C ).
The effects of siTmod1a and siTmod1b injection were similar in Tmod4 +/+ and Tmod4 -/-muscles ( Fig. 5A-C) , despite substantially higher Tmod1 mRNA levels and Tmod1 protein levels in Tmod4 -/-muscles prior to injection (Fig. 3) . Tmod3 remained localized to Z-lineflanking and M-line puncta in siTmod1a-and siTmod1b-injected muscles (Fig. S5A,B Tmod1-negative fibers in siTmod1a-and siTmod1b-injected TA muscles exhibited a wider breadth of sarcomeric F-actin staining, indicative of increased thin filament lengths (Fig.   5A ,B, yellow brackets). Indeed, thin filament lengths in Tmod1-positive fibers were ~0.98 µm, while thin filament lengths in Tmod1-negative knockdown fibers increased to ~1.13 µm (Fig. 5D ). This ~15% increase is slightly greater than the ~10% increase observed in dystrophic TA muscles exhibiting m-calpain-mediated proteolysis of Tmod1 (Gokhin et al., 2014b) , suggesting that residual unproteolyzed Tmod1 remaining in dystrophic TA muscle Development • Advance article might still confer partial length-regulating activity. Neb-N remained normally localized at ~0.95 μm from the Z-line in siTmod1a-and siTmod1b-injected muscles ( Fig. S5C-E ),
indicating that overall thin filament elongation was driven specifically by elongation of the nebulin-free distal segment and not the nebulin-coated proximal segment (Gokhin and Fowler, 2013) . Depletion of Tmod1 from Tmod4 +/+ fibers did not affect variability of thin filament lengths (Fig. 5D and data not shown), even though the abundance of Tmod1
indicates it caps just a subset (~10%) of thin filaments (Table 1) . Notably, Tmod4 remained normally localized at the pointed ends of the elongated thin filaments in siTmod1a-and siTmod1b-injected Tmod4 +/+ muscles (Fig. 6A,C Increased thin filament lengths in Tmod1-negative fibers were associated with increased sarcomere lengths at an ankle joint angle corresponding to maximal plantarflexion ( 
Tmod regulation of thin filament lengths
Our finding that RNAi depletion of Tmod1 leads to thin filament elongation in both wild-type and Tmod4-deficient TA muscle fibers provides the first direct demonstration that pointedend capping by a sarcomeric Tmod isoform is inversely related to thin filament length in mammalian skeletal muscle fibers. While it has been known for some time that pointed-end capping by sarcomeric Tmods in inversely related to thin filament length in cardiac myocytes as well as Drosophila indirect flight muscle (Bliss et al., 2014; Gregorio et al., 1995; Littlefield et al., 2001; Mardahl-Dumesnil and Fowler, 2001; Sussman et al., 1998) , the only evidence for Tmod participation in thin filament length regulation in skeletal muscle has been indirect evidence obtained from dystrophic mouse muscles, in which m-calpain-induced proteolysis of Tmod1 is associated with thin filament elongation (Gokhin et al., 2014b) .
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However, the utility of dystrophic muscles for studying Tmod-mediated thin filament length regulation is constrained by the fact that residual unproteolyzed Tmod remains in muscle after Ca 2+ influx and m-calpain induction, and that the extent of m-calpain proteolysis is highly variable and depends on both the muscle type and the severity of the dystrophy (Gokhin et al., 2014b) . Moreover, thin filament elongation in dystrophic muscle could be due to m-calpain proteolysis of non-Tmod components (Tidball and Spencer, 2000) . The RNAi approach utilized here overcomes these limitations and illuminates a direct link between Tmod1-mediated capping and thin filament length regulation in both normal (wild-type) and developmentally compensated (Tmod4-deficient) contexts.
In wild-type muscles, only ~10% of filaments are capped by Tmod1 (with the remainder capped by Tmod4). Upon siRNA depletion of Tmod1 from wild-type muscles, Tmod4 now caps the pointed ends of all of the now-longer thin filaments. This is consistent with dynamic capping by Tmod4, as previously observed for Tmod1 in chick cardiac myocytes and quail skeletal myotubes (Gregorio et al., 1995; Littlefield et al., 2001; Pappas et al., 2010) . In cardiac myocytes, thin filament lengths are thought to arise from competition between Tmod1 and actin subunits at pointed ends, and, thus, reduced total Tmod would be expected to allow more frequent actin subunit addition, leading to thin filament elongation (Gregorio et al., 1995; Littlefield et al., 2001) . Thin filament elongation is unlikely to be due to lower affinity of Tmod4 for thin filament pointed ends as compared to Tmod1, since no differences have been observed between Tmod1 and Tmod4 with respect to their actin-capping and tropomyosin-actin-capping activities (Almenar-Queralt et al., 1999) . Notably, length uniformity is maintained after thin filament elongation, indicative of a constitutive mechanism for equalization of thin filament lengths across the sarcomere; such a constitutive mechanism for organelle size control has previously been proposed for Chlamydomonas
flagella (Ludington et al., 2012).
Despite compensatory upregulation of Tmod1 and normal thin filament lengths in Tmod4-deficient muscles, Tmod4-deficient muscles provide novel insights into mechanisms of Tmod1+4 levels leading to uncapped pointed ends might reduce total Tmod levels below a threshold required to inhibit actin subunit association and filament lengthening. (2) Alternatively, Tmod1-deficient sarcomeres from Tmod4-deficient muscles might actually have a greater propensity for thin filament elongation due to further reductions in total Tmod and increased actin subunit association kinetics as compared to Tmod1-deficient sarcomeres from wild-type muscles, but, in this latter case, excessive elongation of uncapped thin filaments might be blocked by a structural constraint or "ceiling" on thin filament elongation within the sarcomere. Myosin thick filaments, titin, and/or M-line components may contribute to such a ceiling, as suggested previously (Littlefield and Fowler, 1998) . 
Relationship between Tmods and Lmods in striated muscles
Immunostaining and confocal microscopy
TA and soleus muscles were relaxed, fixed, cryosectioned, and immunostained as described previously (Gokhin et al., 2014b) . Alexa 488-or Alexa 647-conjugated secondary antibodies were supplemented with rhodamine-phalloidin (1:100; Life Technologies) to stain F-actin.
Images of single optical sections were collected at RT on either a Bio-Rad Radiance 2100
laser-scanning confocal microscope mounted on a Nikon TE2000-U microscope, or on a Zeiss LSM780 laser-scanning confocal microscope mounted on a Zeiss Axio Observer.Z1 microscope. Images were acquired using 100× (1.4 NA) Plan-Apochromat oil-objective lenses with digital zoom of up to 3×. Images were processed with Volocity 6.3 (PerkinElmer, Waltham, MA), and image figures were constructed in Adobe Illustrator CS5.1.
Thin filament length measurements
DDecon was used to measure distances of sarcomeric Tmods, neb-N, and Lmod3 from the Zline as well as the breadth of the F-actin (phalloidin) signal across the Z-lines of adjacent half-sarcomeres (I-Z-I arrays) using line-scans of fluorescence images, as described previously (Gokhin et al., 2012; Littlefield and Fowler, 2002 
Histology
Transverse sections of TA, EDL, and soleus muscles were subjected to H&E and Gömöri trichrome staining. Images were collected on a Zeiss Axioskop bright-field microscope using a 10× (0.45 NA) air-objective lens (zoom = 2) and a Zeiss Axiocam CCD camera at RT.
Centrally nucleated fibers were manually counted in H&E-stained images. Fiber crosssectional area was determined by manual segmentation of fibers and converting enclosed pixel areas into μm 2 .
Coimmunoprecipitation
Coimmunoprecipitation was performed as described previously (Gokhin and Fowler, 2011a) .
Briefly, mouse TA and EDL muscles homogenized in RIPA buffer supplemented with protease inhibitor cocktail (1:1000) and centrifuged at 10,000g. The resulting supernatant was divided into 1-ml aliquots, to which one of the following was added: 2 μg rabbit polyclonal anti-Tmod4 (R3577), 2 μg rabbit polyclonal anti-human Tmod1 (R1749), or 2 μg of preimmune control IgG. Antibody-bound complexes were absorbed to 100 μl μMACS Protein A-conjugated super-paramagnetic MicroBeads (Miltenyi Biotec, San Diego, CA) and incubated for 1 h on ice, followed by passage through a μColumn (Miltenyi Biotec) using a μMACS magnetic separator (Miltenyi Biotec). Beads were washed with RIPA buffer and eluted with 100 μl of 1× SDS sample buffer. The input extract (diluted in 2× SDS sample buffer) and eluted immunoprecipitates were then subjected to SDS-PAGE and western blotting, as described below.
Gel sample preparation and western blotting
For western blots of whole-muscle homogenates, TA, EDL, soleus, diaphragm, and neonatal leg and flank muscles were dissected in ice-cold PBS and homogenized with a Tekmar
Tissumizer in 10 volumes of PBS supplemented with protease inhibitor cocktail (1:1000).
Protein standards for quantitative western blotting were prepared as described previously (Gokhin et al., 2014b) . First, protein standards for SDS-PAGE and Coomassie blue staining to determine actin concentrations in isolated myofibrils were prepared from rabbit skeletal muscle actin (Cytoskeleton, Denver, CO). Second, protein standards for quantitative western blots were prepared by spiking increasing volumes of Tmod1 -/- (Gokhin et al., 2010) or Development • Advance article
Tmod4
-/-TA muscle homogenates with increasing amounts of recombinant purified human Tmod1 or mouse Tmod4 proteins (Yamashiro et al., 2010) , respectively. This approach equalized the effects of endogenous non-Tmod proteins on the differential western transfer efficiencies of endogenous vs. recombinant purified Tmods, as described previously (Gokhin et al., 2014b) .
All protein preparations were solubilized in equal volumes of 2× SDS sample buffer and boiled for 5 min. SDS-PAGE, transfer to nitrocellulose, blocking, and antibody incubations were performed as described previously (Gokhin et al., 2014b) . Bands were visualized using a LI-COR Odyssey® infrared imaging system, and background-corrected band intensities were densitometrically quantified in ImageJ. Where appropriate, band intensities were normalized to GAPDH to control for loading.
MHC isoform composition
Gel samples of whole-muscle homogenates were prepared as described under "Western blotting" above. Proteins were then separated via SDS-PAGE on 8% Tris-glycine mini-gels, as described previously (Talmadge and Roy, 1993) . SDS-PAGE was performed for 16 h at 140 V. The upper tank buffer was supplemented with 1 mM DTT, and the lower tank buffer was 1/6 th the concentration of the upper tank buffer (Kohn and Myburgh, 2006) . Gels were silver-stained, and background-corrected intensities of type-1, -2A, -2X, and -2B MHC bands were densitometrically quantified in ImageJ.
Skinned muscle fiber mechanics
Physiological measurement of specific force production, rate constant of force redevelopment after unloaded sarcomere shortening (ktr), thin filament Ca 2+ sensitivity (pCa50), and cooperativity of thin filament activation (Hill coefficient (nH)) using skinned, Ca 2+ -activated TA muscle fibers was performed as described previously (Ochala et al., 2014) .
RNA sequencing
RNA sequencing was performed as described previously (Christodoulou et al., 2011) .
Briefly, an RNA sequencing library was constructed via random hexamer priming of mRNA Development • Advance article pooled from three biological replicates of wild-type mouse TA, soleus, diaphragm, and left ventricular muscles (Domenighetti et al., 2014) . The resulting cDNA library was uniformly amplified to subsaturating levels. Alignment of reads was performed using TopHat 1.0.14 (Trapnell et al., 2009) . Read-depth profiles were constructed using TopHat's "wiggles" tool, and values were normalized to total aligned reads and uploaded onto the University of California-Santa Cruz Genome Browser (http://genome.ucsc.edu).
qRT-PCR
Total RNA was extracted from skeletal muscle tissues with TRIzol reagent (Life Tmod4 and Tmod1 primers were as in (Gokhin et al., 2014b) , Lmod3 and Lmod2 primers were as in (Cenik et al., 2015) , and Gapdh primers were ReadyMade™ primers from Integrated DNA Technologies. Relative gene expression levels were calculated as 2 -ΔΔCt with normalization to Gapdh, as described previously (Livak and Schmittgen, 2001 ).
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In vivo RNAi
Mice were anesthetized with isoflurane (4% for induction, 2% for maintenance) with 1 L/min O2, until cessation of the toe-pinch withdrawal reflex was attained. One nmol siRNA and Lipofectamine® RNAiMAX transfection reagent (1:100, Life Technologies) were diluted to a final volume of 10 µl, drawn into a 25-gauge syringe needle, and slowly injected into the midbelly of the TA muscle. Two different Silencer® Select siRNA constructs (Life Technologies) were used to knockdown Tmod1: siTmod1a forward, 5'-CUAGAAGAGGUUAAUCUUATT-3'; siTmod1a reverse, 5'-UAAGAUUAACCUCUUCUAGTT-3'; siTmod1b forward, 5'-GCUGAAAUGCUGAAAGUGATT-3'; siTmod1b reverse, 5'-UCACUUUCAGCAUUUCAGCAA-3'.
As a negative control, a Stealth™ RNAi negative control duplex (Life Technologies) was used and is referred to as siScr. After injection, the ankle joint was passively dorsi-and plantarflexed to facilitate distribution of injectate throughout the TA, and mice were removed from anesthesia and allowed to recover on a heated pad. After 1 wk, TA muscles were excised and processed for immunostaining and confocal microscopy, as described above. (Fowler et al., 1993) .
Statistics
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